Myasthenia gravis induced by ipilimumab in patients with metastatic melanoma Journal Article


Authors: Johnson, D. B.; Saranga-Perry, V.; Lavin, P. J. M.; Bryan, Burnette, W.; Clark, S. W.; Uskavitch, D. R.; Wallace, D. E.; Dickson, M. A.; Kudchadkar, R. R.; Sosman, J. A.
Article Title: Myasthenia gravis induced by ipilimumab in patients with metastatic melanoma
Keywords: human tissue; aged; prednisone; fatigue; case report; cancer growth; drug withdrawal; paclitaxel; cancer adjuvant therapy; cancer staging; drug megadose; neuroimaging; nuclear magnetic resonance imaging; positron emission tomography; lymph node dissection; sentinel lymph node biopsy; carboplatin; ipilimumab; multiple cycle treatment; skin defect; plasmapheresis; dyspnea; pruritus; rash; dysphagia; acetylsalicylic acid; fluorodeoxyglucose f 18; hypermetabolism; muscle weakness; erythema; methylprednisolone; phase 1 clinical trial; inguinal lymph node; levothyroxine; drug substitution; myasthenia gravis; diplopia; citalopram; adverse drug reaction; photosensitivity; lymphadenopathy; leg disease; cutaneous melanoma; blurred vision; thyrotropin; ptosis; cholinergic receptor; subcutaneous nodule; metastatic melanoma; mitosis index; corticotropin; thyrotropin blood level; trazodone; wide excision; corticosteroid therapy; muscle strength; limb weakness; general condition deterioration; pyridostigmine; human; female; priority journal; article; free thyroxine index; inguinal adenopathy; muscle action potential; myasthenia like syndrome; popliteal adenopathy
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 33
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-11-20
Start Page: e122
End Page: e124
Language: English
DOI: 10.1200/JCO.2013.51.1683
PROVIDER: scopus
PUBMED: 24778401
PMCID: PMC4979104
DOI/URL:
Notes: Article -- Export Date: 7 January 2016 -- e122 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark Andrew Dickson
    169 Dickson